# Avinger Inc. (AVGR)

Source: https://www.quantisnow.com/company/AVGR
Generated: 2026-11-11T19:51:04.545Z

- Ticker: AVGR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2015
- Website: avinger.com

## About

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

## Latest AVGR news and filings

- 2025-02-14 22:07 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Avinger Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-avinger-inc-5891639)
- 2025-02-10 22:01 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Changes in Registrant's Certifying Accountant, Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-entry-into-a-material-5880180)
- 2025-02-05 22:00 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-submission-of-matters-to-5873611)
- 2025-01-25 02:35 UTC [SEC Form 4] [Vice President, Finance Subainati Nabeel Paul sold $699 worth of shares (1,255 units at $0.56), decreasing direct ownership by 28% to 3,296 units (SEC Form 4)](https://www.quantisnow.com/insight/vice-president-finance-subainati-nabeel-paul-sold-699-worth-of-5857217)
- 2025-01-25 02:34 UTC [SEC Form 4] [Chief Executive Officer Soinski Jeffrey M sold $2,054 worth of shares (3,690 units at $0.56), decreasing direct ownership by 6% to 55,265 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-soinski-jeffrey-m-sold-2054-worth-of-5857216)
- 2025-01-25 02:34 UTC [SEC Form 4] [Chief Technology Officer Patel Himanshu sold $1,233 worth of shares (2,215 units at $0.56), decreasing direct ownership by 5% to 39,062 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-patel-himanshu-sold-1233-worth-of-shares-5857215)
- 2025-01-24 21:32 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avinger-inc-5856838)
- 2025-01-24 21:32 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-submission-of-matters-to-5856836)
- 2025-01-23 21:21 UTC [SEC Form 144] [SEC Form 144 filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-avinger-inc-5855476)
- 2025-01-03 22:23 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-other-events-5832654)
- 2025-01-01 00:22 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-unregistered-sales-of-equity-5828359)
- 2024-12-23 13:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-avinger-inc-5823309)
- 2024-12-19 22:17 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-leadership-update-submission-of-5820942)
- 2024-12-13 21:35 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-leadership-update-financial-statements-5813211)
- 2024-12-11 22:23 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation, Other Events](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-events-that-accelerate-or-5809847)
- 2024-12-11 22:19 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-avinger-inc-5809832)
- 2024-11-22 21:30 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-notice-of-delisting-or-5788633)
- 2024-11-14 20:23 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-avinger-inc-5775092)
- 2024-11-13 16:13 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Avinger Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-avinger-inc-5770623)
- 2024-11-07 22:22 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-results-of-operations-and-5760312)
- 2024-11-07 22:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-avinger-inc-5760209)
- 2024-11-07 21:05 UTC [Earnings Date] [Avinger Reports Third Quarter 2024 Results](https://www.quantisnow.com/insight/avinger-reports-third-quarter-2024-results-5759103)
- 2024-11-05 21:32 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-avinger-inc-5753644)
- 2024-11-05 21:31 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-avinger-inc-5753627)
- 2024-10-29 12:00 UTC [Earnings Date] [Avinger to Announce Third Quarter 2024 Results on November 7, 2024](https://www.quantisnow.com/insight/avinger-to-announce-third-quarter-2024-results-on-november-7-5741019)
- 2024-10-24 12:00 UTC [Conference Announcement] [Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention](https://www.quantisnow.com/insight/avinger-releases-updated-data-from-image-btk-in-webinar-featuring-key-5736417)
- 2024-10-18 00:22 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-other-events-financial-statements-5729779)
- 2024-10-17 20:33 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-avinger-inc-5729328)
- 2024-09-18 12:00 UTC [Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents](https://www.quantisnow.com/insight/avinger-announces-issuance-of-new-us-patent-and-receives-notices-5697634)
- 2024-08-20 12:30 UTC [Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device](https://www.quantisnow.com/insight/avinger-initiates-full-commercial-launch-of-pantheris-lv-image-guided-atherectomy-5665826)
- 2024-08-12 21:01 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-submission-of-matters-to-5655344)
- 2024-08-08 21:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-avinger-inc-5651446)
- 2024-08-08 20:25 UTC [SEC Form 8-K] [Avinger Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/avinger-inc-filed-sec-form-8-k-results-of-operations-and-5651055)
- 2024-08-08 20:01 UTC [Public Offering] [Avinger Reports Second Quarter 2024 Results](https://www.quantisnow.com/insight/avinger-reports-second-quarter-2024-results-5650211)
- 2024-08-05 12:00 UTC [Leadership Update] [Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer](https://www.quantisnow.com/insight/avinger-appoints-thomas-p-davis-md-facc-as-chief-medical-5641507)
- 2024-07-29 12:45 UTC [Earnings Date] [Avinger to Announce Second Quarter 2024 Results on August 8, 2024](https://www.quantisnow.com/insight/avinger-to-announce-second-quarter-2024-results-on-august-8-5630863)
- 2024-07-11 21:19 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-avinger-inc-5604892)
- 2024-07-01 12:32 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-avinger-inc-5585544)
- 2024-06-21 20:45 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Avinger Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-avinger-inc-5571515)
- 2024-06-17 20:05 UTC [Public Offering] [Avinger Announces Closing of up to $24 Million Public Offering](https://www.quantisnow.com/insight/avinger-announces-closing-of-up-to-24-million-public-offering-5562004)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AVGR
- Earnings history: https://www.quantisnow.com/earnings/AVGR
- Dividend history: https://www.quantisnow.com/dividends/AVGR
- Insider transactions: https://www.quantisnow.com/insiders/AVGR
- Options chain: https://www.quantisnow.com/options/AVGR
- SEC 8-K filings only: https://www.quantisnow.com/company/AVGR/8-k
- RSS and alerts for AVGR: https://www.quantisnow.com/docs/rss-feeds.md